Escitalopram can reduce the levels of pro-inflammatory cytokines—IL-1β, IL-1ra, IL-2, IL-4, IL-6, IL-8, IFN-y, TNF-α in the serum of patients suffering from depression [56], while simultaneously increasing the level of anti-inflammatory IL-10 [57]. The gene discussed is IL1B; the disease is depressive disorder.